Molly B. Schmid, Ph.D. is Vice President of the Inland Empire network of the Tech Coast Angels and a member of the TCA Board of Directors. She has specific expertise in early stage biotechnology companies, stemming from her own roles in scientific management, project leadership, and business development in three biotechnology companies. Her career has been about equally split between academia and industry.
Most recently, she was Professor and Entrepreneur-in-Residence at Keck Graduate Institute of Applied Life Sciences and Adjunct Professor at the Drucker School of Management in Claremont CA, where she taught courses in drug discovery and entrepreneurship, and chaired the intellectual property committee.
She has served as a judge for numerous entrepreneurship competitions, including the Tech Coast Angels San Diego Fast Pitch Competition, Chapman University California Dreamin’ Business Plan Competition, Orange County TCA Fast Pitch Competition, SoCalBio’s Investor Conference Screening Panel, and Claremont’s Kravis Competition.
Prior to KGI, she was Senior Vice President of Preclinical Programs at Affinium Pharmaceuticals in Toronto, and held leadership positions at Genencor International and Microcide Pharmaceuticals. Her experiences with these companies included securing venture capital, securing and managing multi-year, multi-million dollar corporate partnerships with Pfizer, Johnson & Johnson, Daiichi Pharmaceuticals, and several other smaller pharmaceutical and biotechnology companies and playing leadership roles in growing and managing the scientific staff. These three biotech companies provided a wide range of experiences – two companies had IPO’s, there were two compounds that entered clinical trials, and two companies that ended in Chapter 11 reorganizations. She has nine issued U.S. patents, and several others pending.
Prior to her biotech experience, she was an Assistant Professor of Molecular Biology at Princeton University, where she secured over $1MM in research funding. She has served on numerous NSF and NIH grant review panels, and she chaired a SBIR grant review panel for several years. She is a Fellow of the American Academy of Microbiology, a Searle Scholar, and a Damon-Runyon Fellow.